RxSight, Inc. (NASDAQ: RXST)
$33.1900
-1.3100 ( -3.41% ) 377.7K
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
Market Data
Open
$33.1900
Previous close
$34.5000
Volume
377.7K
Market cap
$1.35B
Day range
$33.0290 - $35.7040
52 week range
$33.0290 - $66.5400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | May 21, 2024 |
4 | Insider transactions | 1 | May 20, 2024 |
8-k | 8K-related | 18 | May 09, 2024 |
4 | Insider transactions | 1 | May 06, 2024 |
8-k | 8K-related | 13 | May 06, 2024 |
10-q | Quarterly Reports | 65 | May 06, 2024 |
4 | Insider transactions | 1 | May 02, 2024 |
def | Proxies and info statements | 9 | Apr 25, 2024 |
ars | Annual reports | 1 | Apr 25, 2024 |
8-k | 8K-related | 11 | Apr 23, 2024 |